FORA Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,668
| Closed | -$203K | – | 673 |
|
|
2023
Q3 | $203K | Buy |
+4,668
| New | +$203K | 0.02% | 435 |
|
|
2022
Q4 | – | Sell |
-5,110
| Closed | -$357K | – | 663 |
|
|
2022
Q3 | $357K | Buy |
+5,110
| New | +$357K | 0.07% | 301 |
|
|
2022
Q2 | – | Sell |
-4,570
| Closed | -$380K | – | 735 |
|
|
2022
Q1 | $380K | Buy |
4,570
+1,808
| +65% | +$150K | 0.07% | 335 |
|
|
2021
Q4 | $405K | Buy |
+2,762
| New | +$405K | 0.16% | 178 |
|
|
2021
Q3 | – | Sell |
-1,242
| Closed | -$201K | – | 934 |
|
|
2021
Q2 | $201K | Buy |
+1,242
| New | +$201K | 0.04% | 440 |
|
|
2021
Q1 | – | Sell |
-4,347
| Closed | -$955K | – | 1187 |
|
|
2020
Q4 | $955K | Buy |
4,347
+2,475
| +132% | +$544K | 0.15% | 160 |
|
|
2020
Q3 | $311K | Sell |
1,872
-4,632
| -71% | -$770K | 0.2% | 112 |
|
|
2020
Q2 | $743K | Buy |
+6,504
| New | +$743K | 0.25% | 98 |
|
|
2020
Q1 | – | Sell |
-4,015
| Closed | -$517K | – | 1411 |
|
|
2019
Q4 | $517K | Buy |
+4,015
| New | +$517K | 0.05% | 382 |
|